- Home
- PYPD vs FOFO Comparison
PYPD vs FOFO Comparison
Compare PYPD & FOFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PYPD | FOFO |
|---|---|---|
| Founded | 2008 | 2017 |
| Country | Israel | Hong Kong |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 77.4M | 85.2M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | PYPD | FOFO |
|---|---|---|
| Price | $4.31 | $4.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 41.7K | 40.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.09 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.30 | $2.86 |
| 52 Week High | $5.12 | $68.00 |
Technical Indicators
Market Signals| Indicator | PYPD | FOFO |
|---|---|---|
| Relative Strength Index (RSI) | 48.03 | 42.24 |
| Support Level | $4.26 | $2.86 |
| Resistance Level | $4.38 | $6.40 |
| Average True Range (ATR) | 0.17 | 0.44 |
| MACD | -0.00 | 0.15 |
| Stochastic Oscillator | 68.29 | 69.78 |
Price Performance
Historical ComparisonAbout PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About FOFO Hang Feng Technology Innovation Co. Ltd. Ordinary Shares
Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their unique business and investment objectives. Its business consists of two main segments: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting, and Regulatory compliance and governance consulting.